WAT— WATERS CORP /DE/

Health CareLife Sciences Tools & Services$40.4B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Total net sales	$3.17B+7.0%	$2.96B+0.1%	$2.96B-0.5%	$2.97B
Costs and operating expenses	$1.29B+7.4%	$1.20B+56.6%	$766.4M-8.4%	$836.2M
Selling and administrative expenses	$830.4M+20.3%	$690.1M-6.2%	$736.0M+11.9%	$658.0M
Research and development expenses	$195.7M+6.9%	$183.0M+4.6%	$174.9M-0.7%	$176.2M
Purchased intangibles amortization	$47.8M+1.5%	$47.1M+44.6%	$32.6M+411.4%	$6.4M
Litigation provisions	$0-100.0%	$11.6M	$0	$0
Total costs and operating expenses	$2.36B+10.8%	$2.13B-0.3%	$2.14B+1.9%	$2.10B
Operating income	$802.6M-2.9%	$826.4M+1.1%	$817.7M-6.4%	$873.4M
Other income, net	$3.1M+294.5%	$776K-3.8%	$807K-63.8%	$2.2M
Interest expense	-$69.5M+22.4%	-$89.7M+9.3%	-$98.9M-102.6%	-$48.8M
Interest income	$18.8M+7.8%	$17.4M+4.8%	$16.6M+50.8%	$11.0M
Income before income taxes	$754.9M+0.0%	$754.9M+2.5%	$736.2M-12.1%	$837.8M
Provision for income taxes	$112.2M-4.1%	$117.0M+24.5%	$94.0M-27.7%	$130.1M
Net income	$642.6M+0.8%	$637.8M-0.7%	$642.2M-9.3%	$707.8M
Net income per basic common share	$10800.00+0.5%	$10750.00-1.1%	$10870.00-7.9%	$11800.00
Weighted-average number of basic common shares	59.5M+0.3%	59.3M+0.4%	59.1M-1.5%	60.0M
Net income per diluted common share	$10760.00+0.5%	$10710.00-1.2%	$10840.00-7.6%	$11730.00
Weighted-average number of diluted common shares and equivalents	59.7M+0.3%	59.6M+0.5%	59.3M-1.8%	60.3M
Product [Member]
Service [Member]

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.